Interestingly, MYLK, MYH11, and FLNC were identified as pivotal genes in studies of the immune microenvironment [42], and MYLK and FLNC were found to be associated with prostate pathogenesis and prognosis [43]. This evidence concerns the gene MYLK and male reproductive organ cancer.